ArticleJournal of clinical immunology2019

Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT.

Rebecca A Marsh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.